Business in the Burbs

Accorda announces vice president appointment

April

Acorda Therapeutics Inc., the biopharmaceutical company in Hawthorne, said this morning that Dr. Anthony Caggiano has been promoted to vice president of preclinical development.

He will continue to manage the preclinical and research and development departments, the company said. He will also oversee the company’s preclinical programs that seek to develop treatments for multiple sclerosis, spinal cord injuries and other neurological disorders.

Caggiano joined the company in September 2001 as a laboratory scientist and has held a number of positions since then.

This entry was posted on Friday, April 10th, 2009 at 10:12 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.